DF
Drug FarmDrug Farm is a biotech developing AI-designed small-molecule drugs for rare and immune-inflammatory diseases, led by DF-003, a Phase 3 ALPK1 inhibitor for ROSAH syndrome.
2 Pulse stories
S
ShionogiJapanese pharmaceutical company developing prescription drugs, infectious disease therapies, and specialty medicines, including a former sleep apnea drug joint venture with Apnimed.
2 Pulse stories
Total Raised
$138M
Drug FarmShionogi
Last ValuationNot disclosed
Biotech
Sector
Biotech
2015
Founded
1878
Shanghai, China / New York, NY
HQ
Osaka, Japan
Private
Status
Public (4507.T)
Drug Farm investors
Shanghai Pudong Leading Area Investment CenterShanghai Puxing Collaborative Private Equity FundDetong CapitalWuXi AppTecBioVeda China FundYD CapitalBetta CapitalWedo Venture Management
Shionogi investors
No investors on record.
Data from Value Add Pulse coverage and company research — see the full threads for Drug Farm and Shionogi.